Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Tracon Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Tracon Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Brown Scott B. | CHIEF FINANCIAL OFFICER | 25,128 | Mar 13, 2024 | 0 |
| Theuer Charles | PRESIDENT AND CEO | 406,417 | Mar 13, 2024 | 0 |
| Opaleye Management Inc. | 10% Owner | 0Indirect | Nov 14, 2023 | 0 |
| Pelletier Saundra L | Director | 12,045 | Apr 21, 2023 | 0 |
| Mattingly Martin A | Director | – | Apr 21, 2023 | 0 |
| Larue William R | Director | 7,763 | Apr 21, 2023 | 0 |
| Worland Stephen T | Director | – | Apr 21, 2023 | 0 |
| Twiford J Rainer | Director | – | Apr 21, 2023 | 0 |
| Lam Carol C. | Director | – | Apr 21, 2023 | 0 |
| Johnson-Pratt Lisa | Director | – | Apr 21, 2023 | 0 |
| Adams Bonne J. | Chief Operating Officer | – | Feb 9, 2023 | 0 |
| Wiggins Mark C | Chief Business Officer | – | Feb 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 (view filing) | Dec 14 | 1 day | Theuer CharlesPresident and CEO | PPurchase | +23.0K | $1.29 | +$29.7K | +7.4%333.1K after | |
| Dec 16, 2022 (view filing) | Dec 14 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +167.5K | $1.26 | +$210.5K | +61.5%440.0K after | 2 lots |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Brown Scott B.Chief Financial Officer | PPurchase | +3.50K | $1.49 | +$5.21K | +19.3%21.6K after | |
| Jan 19, 2023 (view filing) | Dec 21, 2022 | 29 daysLate | Larue William RDirector | SSale | −120 | $1.26 | −$151.2 | −1.5%7.76K after | |
| Jan 19, 2023 (view filing) | Jan 18 | 1 day | Theuer CharlesPresident and CEO | PPurchase | +6.80K | $1.62 | +$11.0K | +2.0%339.9K after | |
| Mar 2, 2023 (view filing) | Feb 28-Mar 1 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +5.00K | $1.52 | +$7.60K | +1.5%344.9K after | 2 lots |
| Mar 13, 2023 (view filing) | Mar 9 | 4 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +174.5K | $1.38 | +$240.8K | +4.2%4.32M after | |
| Apr 28, 2023 (view filing) | Apr 26-27 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +51.0K | $0.7429 | +$37.9K | +14.6%399.4K after | 2 lots |
| Nov 14, 2023 (view filing)4:05 PM ET | Nov 10 | 4 days | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −4.76M | $0.2942 | −$1.40M | −100.0%0 after | 2 lots |